【Description】
Nucleic acid amplification technologies are used for the rapid and accurate diagnosis of chronic and infectious diseases. The nucleic acid amplification is one of the important tool for wide aspects of life science technologies including, clinical medicine development, diagnosis of infectious diseases, and gene cloning.
The global market for Nucleic Acid Amplification Detection and Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Amplification Detection and Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Nucleic Acid Amplification Detection and Diagnostics by region & country, by Type, and by Application.
The Nucleic Acid Amplification Detection and Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Amplification Detection and Diagnostics.
Market Segmentation
By Company
BD
BioMerieux SA
BIO-RAD LABORATORIES INC.
THERMO FISHER SCIENTIFIC INC.
Illumina, Inc.
Danaher
QIAGEN
Abbott
Meridian Bioscience, Inc.
F. Hoffmann-La Roche Ltd.
PreAnalytiX
Eiken Chemical
Lucigen
OptiGene
NEB
Quidel Corporation
Promega
Hologic
Ustar
Grifols
Nugen
Segment by Type:
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Isothermal Amplification Technology
Direct Nucleic Acid Detection
CRISPR-Cas9
Segment by Application
Hospital and Clinics
Diagnostic Centers
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Nucleic Acid Amplification Detection and Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Nucleic Acid Amplification Detection and Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Nucleic Acid Amplification Detection and Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
【Table of Contents】
1 Market Overview
1.1 Nucleic Acid Amplification Detection and Diagnostics Product Introduction
1.2 Global Nucleic Acid Amplification Detection and Diagnostics Market Size Forecast
1.3 Nucleic Acid Amplification Detection and Diagnostics Market Trends & Drivers
1.3.1 Nucleic Acid Amplification Detection and Diagnostics Industry Trends
1.3.2 Nucleic Acid Amplification Detection and Diagnostics Market Drivers & Opportunity
1.3.3 Nucleic Acid Amplification Detection and Diagnostics Market Challenges
1.3.4 Nucleic Acid Amplification Detection and Diagnostics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Nucleic Acid Amplification Detection and Diagnostics Players Revenue Ranking (2023)
2.2 Global Nucleic Acid Amplification Detection and Diagnostics Revenue by Company (2019-2024)
2.3 Key Companies Nucleic Acid Amplification Detection and Diagnostics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Nucleic Acid Amplification Detection and Diagnostics Product Offered
2.5 Key Companies Time to Begin Mass Production of Nucleic Acid Amplification Detection and Diagnostics
2.6 Nucleic Acid Amplification Detection and Diagnostics Market Competitive Analysis
2.6.1 Nucleic Acid Amplification Detection and Diagnostics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Nucleic Acid Amplification Detection and Diagnostics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Amplification Detection and Diagnostics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Polymerase Chain Reaction (PCR)
3.1.2 Next Generation Sequencing (NGS)
3.1.3 Isothermal Amplification Technology
3.1.4 Direct Nucleic Acid Detection
3.1.5 CRISPR-Cas9
3.2 Global Nucleic Acid Amplification Detection and Diagnostics Sales Value by Type
3.2.1 Global Nucleic Acid Amplification Detection and Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Nucleic Acid Amplification Detection and Diagnostics Sales Value, by Type (2019-2030)
3.2.3 Global Nucleic Acid Amplification Detection and Diagnostics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital and Clinics
4.1.2 Diagnostic Centers
4.1.3 Research Institutes
4.1.4 Others
4.2 Global Nucleic Acid Amplification Detection and Diagnostics Sales Value by Application
4.2.1 Global Nucleic Acid Amplification Detection and Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Nucleic Acid Amplification Detection and Diagnostics Sales Value, by Application (2019-2030)
4.2.3 Global Nucleic Acid Amplification Detection and Diagnostics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Nucleic Acid Amplification Detection and Diagnostics Sales Value by Region
5.1.1 Global Nucleic Acid Amplification Detection and Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Nucleic Acid Amplification Detection and Diagnostics Sales Value by Region (2019-2024)
5.1.3 Global Nucleic Acid Amplification Detection and Diagnostics Sales Value by Region (2025-2030)
5.1.4 Global Nucleic Acid Amplification Detection and Diagnostics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Nucleic Acid Amplification Detection and Diagnostics Sales Value, 2019-2030
5.2.2 North America Nucleic Acid Amplification Detection and Diagnostics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Nucleic Acid Amplification Detection and Diagnostics Sales Value, 2019-2030
5.3.2 Europe Nucleic Acid Amplification Detection and Diagnostics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Nucleic Acid Amplification Detection and Diagnostics Sales Value, 2019-2030
5.4.2 Asia Pacific Nucleic Acid Amplification Detection and Diagnostics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Nucleic Acid Amplification Detection and Diagnostics Sales Value, 2019-2030
5.5.2 South America Nucleic Acid Amplification Detection and Diagnostics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Sales Value, 2019-2030
5.6.2 Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Nucleic Acid Amplification Detection and Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Nucleic Acid Amplification Detection and Diagnostics Sales Value
6.3 United States
6.3.1 United States Nucleic Acid Amplification Detection and Diagnostics Sales Value, 2019-2030
6.3.2 United States Nucleic Acid Amplification Detection and Diagnostics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Nucleic Acid Amplification Detection and Diagnostics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Nucleic Acid Amplification Detection and Diagnostics Sales Value, 2019-2030
6.4.2 Europe Nucleic Acid Amplification Detection and Diagnostics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Nucleic Acid Amplification Detection and Diagnostics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Nucleic Acid Amplification Detection and Diagnostics Sales Value, 2019-2030
6.5.2 China Nucleic Acid Amplification Detection and Diagnostics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Nucleic Acid Amplification Detection and Diagnostics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Nucleic Acid Amplification Detection and Diagnostics Sales Value, 2019-2030
6.6.2 Japan Nucleic Acid Amplification Detection and Diagnostics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Nucleic Acid Amplification Detection and Diagnostics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Nucleic Acid Amplification Detection and Diagnostics Sales Value, 2019-2030
6.7.2 South Korea Nucleic Acid Amplification Detection and Diagnostics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Nucleic Acid Amplification Detection and Diagnostics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Nucleic Acid Amplification Detection and Diagnostics Sales Value, 2019-2030
6.8.2 Southeast Asia Nucleic Acid Amplification Detection and Diagnostics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Nucleic Acid Amplification Detection and Diagnostics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Nucleic Acid Amplification Detection and Diagnostics Sales Value, 2019-2030
6.9.2 India Nucleic Acid Amplification Detection and Diagnostics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Nucleic Acid Amplification Detection and Diagnostics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 BD
7.1.1 BD Profile
7.1.2 BD Main Business
7.1.3 BD Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
7.1.4 BD Nucleic Acid Amplification Detection and Diagnostics Revenue (US$ Million) & (2019-2024)
7.1.5 BD Recent Developments
7.2 BioMerieux SA
7.2.1 BioMerieux SA Profile
7.2.2 BioMerieux SA Main Business
7.2.3 BioMerieux SA Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
7.2.4 BioMerieux SA Nucleic Acid Amplification Detection and Diagnostics Revenue (US$ Million) & (2019-2024)
7.2.5 BioMerieux SA Recent Developments
7.3 BIO-RAD LABORATORIES INC.
7.3.1 BIO-RAD LABORATORIES INC. Profile
7.3.2 BIO-RAD LABORATORIES INC. Main Business
7.3.3 BIO-RAD LABORATORIES INC. Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
7.3.4 BIO-RAD LABORATORIES INC. Nucleic Acid Amplification Detection and Diagnostics Revenue (US$ Million) & (2019-2024)
7.3.5 THERMO FISHER SCIENTIFIC INC. Recent Developments
7.4 THERMO FISHER SCIENTIFIC INC.
7.4.1 THERMO FISHER SCIENTIFIC INC. Profile
7.4.2 THERMO FISHER SCIENTIFIC INC. Main Business
7.4.3 THERMO FISHER SCIENTIFIC INC. Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
7.4.4 THERMO FISHER SCIENTIFIC INC. Nucleic Acid Amplification Detection and Diagnostics Revenue (US$ Million) & (2019-2024)
7.4.5 THERMO FISHER SCIENTIFIC INC. Recent Developments
7.5 Illumina, Inc.
7.5.1 Illumina, Inc. Profile
7.5.2 Illumina, Inc. Main Business
7.5.3 Illumina, Inc. Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
7.5.4 Illumina, Inc. Nucleic Acid Amplification Detection and Diagnostics Revenue (US$ Million) & (2019-2024)
7.5.5 Illumina, Inc. Recent Developments
7.6 Danaher
7.6.1 Danaher Profile
7.6.2 Danaher Main Business
7.6.3 Danaher Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
7.6.4 Danaher Nucleic Acid Amplification Detection and Diagnostics Revenue (US$ Million) & (2019-2024)
7.6.5 Danaher Recent Developments
7.7 QIAGEN
7.7.1 QIAGEN Profile
7.7.2 QIAGEN Main Business
7.7.3 QIAGEN Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
7.7.4 QIAGEN Nucleic Acid Amplification Detection and Diagnostics Revenue (US$ Million) & (2019-2024)
7.7.5 QIAGEN Recent Developments
7.8 Abbott
7.8.1 Abbott Profile
7.8.2 Abbott Main Business
7.8.3 Abbott Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
7.8.4 Abbott Nucleic Acid Amplification Detection and Diagnostics Revenue (US$ Million) & (2019-2024)
7.8.5 Abbott Recent Developments
7.9 Meridian Bioscience, Inc.
7.9.1 Meridian Bioscience, Inc. Profile
7.9.2 Meridian Bioscience, Inc. Main Business
7.9.3 Meridian Bioscience, Inc. Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
7.9.4 Meridian Bioscience, Inc. Nucleic Acid Amplification Detection and Diagnostics Revenue (US$ Million) & (2019-2024)
7.9.5 Meridian Bioscience, Inc. Recent Developments
7.10 F. Hoffmann-La Roche Ltd.
7.10.1 F. Hoffmann-La Roche Ltd. Profile
7.10.2 F. Hoffmann-La Roche Ltd. Main Business
7.10.3 F. Hoffmann-La Roche Ltd. Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
7.10.4 F. Hoffmann-La Roche Ltd. Nucleic Acid Amplification Detection and Diagnostics Revenue (US$ Million) & (2019-2024)
7.10.5 F. Hoffmann-La Roche Ltd. Recent Developments
7.11 PreAnalytiX
7.11.1 PreAnalytiX Profile
7.11.2 PreAnalytiX Main Business
7.11.3 PreAnalytiX Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
7.11.4 PreAnalytiX Nucleic Acid Amplification Detection and Diagnostics Revenue (US$ Million) & (2019-2024)
7.11.5 PreAnalytiX Recent Developments
7.12 Eiken Chemical
7.12.1 Eiken Chemical Profile
7.12.2 Eiken Chemical Main Business
7.12.3 Eiken Chemical Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
7.12.4 Eiken Chemical Nucleic Acid Amplification Detection and Diagnostics Revenue (US$ Million) & (2019-2024)
7.12.5 Eiken Chemical Recent Developments
7.13 Lucigen
7.13.1 Lucigen Profile
7.13.2 Lucigen Main Business
7.13.3 Lucigen Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
7.13.4 Lucigen Nucleic Acid Amplification Detection and Diagnostics Revenue (US$ Million) & (2019-2024)
7.13.5 Lucigen Recent Developments
7.14 OptiGene
7.14.1 OptiGene Profile
7.14.2 OptiGene Main Business
7.14.3 OptiGene Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
7.14.4 OptiGene Nucleic Acid Amplification Detection and Diagnostics Revenue (US$ Million) & (2019-2024)
7.14.5 OptiGene Recent Developments
7.15 NEB
7.15.1 NEB Profile
7.15.2 NEB Main Business
7.15.3 NEB Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
7.15.4 NEB Nucleic Acid Amplification Detection and Diagnostics Revenue (US$ Million) & (2019-2024)
7.15.5 NEB Recent Developments
7.16 Quidel Corporation
7.16.1 Quidel Corporation Profile
7.16.2 Quidel Corporation Main Business
7.16.3 Quidel Corporation Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
7.16.4 Quidel Corporation Nucleic Acid Amplification Detection and Diagnostics Revenue (US$ Million) & (2019-2024)
7.16.5 Quidel Corporation Recent Developments
7.17 Promega
7.17.1 Promega Profile
7.17.2 Promega Main Business
7.17.3 Promega Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
7.17.4 Promega Nucleic Acid Amplification Detection and Diagnostics Revenue (US$ Million) & (2019-2024)
7.17.5 Promega Recent Developments
7.18 Hologic
7.18.1 Hologic Profile
7.18.2 Hologic Main Business
7.18.3 Hologic Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
7.18.4 Hologic Nucleic Acid Amplification Detection and Diagnostics Revenue (US$ Million) & (2019-2024)
7.18.5 Hologic Recent Developments
7.19 Ustar
7.19.1 Ustar Profile
7.19.2 Ustar Main Business
7.19.3 Ustar Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
7.19.4 Ustar Nucleic Acid Amplification Detection and Diagnostics Revenue (US$ Million) & (2019-2024)
7.19.5 Ustar Recent Developments
7.20 Grifols
7.20.1 Grifols Profile
7.20.2 Grifols Main Business
7.20.3 Grifols Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
7.20.4 Grifols Nucleic Acid Amplification Detection and Diagnostics Revenue (US$ Million) & (2019-2024)
7.20.5 Grifols Recent Developments
7.21 Nugen
7.21.1 Nugen Profile
7.21.2 Nugen Main Business
7.21.3 Nugen Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
7.21.4 Nugen Nucleic Acid Amplification Detection and Diagnostics Revenue (US$ Million) & (2019-2024)
7.21.5 Nugen Recent Developments
8 Industry Chain Analysis
8.1 Nucleic Acid Amplification Detection and Diagnostics Industrial Chain
8.2 Nucleic Acid Amplification Detection and Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Nucleic Acid Amplification Detection and Diagnostics Sales Model
8.5.2 Sales Channel
8.5.3 Nucleic Acid Amplification Detection and Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
【Table of Figures】
List of Tables
Table 1. Nucleic Acid Amplification Detection and Diagnostics Market Trends
Table 2. Nucleic Acid Amplification Detection and Diagnostics Market Drivers & Opportunity
Table 3. Nucleic Acid Amplification Detection and Diagnostics Market Challenges
Table 4. Nucleic Acid Amplification Detection and Diagnostics Market Restraints
Table 5. Global Nucleic Acid Amplification Detection and Diagnostics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Nucleic Acid Amplification Detection and Diagnostics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Nucleic Acid Amplification Detection and Diagnostics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Nucleic Acid Amplification Detection and Diagnostics Product Type
Table 9. Key Companies Time to Begin Mass Production of Nucleic Acid Amplification Detection and Diagnostics
Table 10. Global Nucleic Acid Amplification Detection and Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Amplification Detection and Diagnostics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Nucleic Acid Amplification Detection and Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Nucleic Acid Amplification Detection and Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Nucleic Acid Amplification Detection and Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Nucleic Acid Amplification Detection and Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Nucleic Acid Amplification Detection and Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Nucleic Acid Amplification Detection and Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Nucleic Acid Amplification Detection and Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Nucleic Acid Amplification Detection and Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Nucleic Acid Amplification Detection and Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Nucleic Acid Amplification Detection and Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Nucleic Acid Amplification Detection and Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Nucleic Acid Amplification Detection and Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Nucleic Acid Amplification Detection and Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Nucleic Acid Amplification Detection and Diagnostics Sales Value by Region (2019-2024) & (%)
Table 27. Global Nucleic Acid Amplification Detection and Diagnostics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Nucleic Acid Amplification Detection and Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Nucleic Acid Amplification Detection and Diagnostics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Nucleic Acid Amplification Detection and Diagnostics Sales Value, (2025-2030) & (US$ Million)
Table 31. BD Basic Information List
Table 32. BD Description and Business Overview
Table 33. BD Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Nucleic Acid Amplification Detection and Diagnostics Business of BD (2019-2024)
Table 35. BD Recent Developments
Table 36. BioMerieux SA Basic Information List
Table 37. BioMerieux SA Description and Business Overview
Table 38. BioMerieux SA Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Nucleic Acid Amplification Detection and Diagnostics Business of BioMerieux SA (2019-2024)
Table 40. BioMerieux SA Recent Developments
Table 41. BIO-RAD LABORATORIES INC. Basic Information List
Table 42. BIO-RAD LABORATORIES INC. Description and Business Overview
Table 43. BIO-RAD LABORATORIES INC. Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Nucleic Acid Amplification Detection and Diagnostics Business of BIO-RAD LABORATORIES INC. (2019-2024)
Table 45. BIO-RAD LABORATORIES INC. Recent Developments
Table 46. THERMO FISHER SCIENTIFIC INC. Basic Information List
Table 47. THERMO FISHER SCIENTIFIC INC. Description and Business Overview
Table 48. THERMO FISHER SCIENTIFIC INC. Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Nucleic Acid Amplification Detection and Diagnostics Business of THERMO FISHER SCIENTIFIC INC. (2019-2024)
Table 50. THERMO FISHER SCIENTIFIC INC. Recent Developments
Table 51. Illumina, Inc. Basic Information List
Table 52. Illumina, Inc. Description and Business Overview
Table 53. Illumina, Inc. Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Nucleic Acid Amplification Detection and Diagnostics Business of Illumina, Inc. (2019-2024)
Table 55. Illumina, Inc. Recent Developments
Table 56. Danaher Basic Information List
Table 57. Danaher Description and Business Overview
Table 58. Danaher Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Nucleic Acid Amplification Detection and Diagnostics Business of Danaher (2019-2024)
Table 60. Danaher Recent Developments
Table 61. QIAGEN Basic Information List
Table 62. QIAGEN Description and Business Overview
Table 63. QIAGEN Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Nucleic Acid Amplification Detection and Diagnostics Business of QIAGEN (2019-2024)
Table 65. QIAGEN Recent Developments
Table 66. Abbott Basic Information List
Table 67. Abbott Description and Business Overview
Table 68. Abbott Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Nucleic Acid Amplification Detection and Diagnostics Business of Abbott (2019-2024)
Table 70. Abbott Recent Developments
Table 71. Meridian Bioscience, Inc. Basic Information List
Table 72. Meridian Bioscience, Inc. Description and Business Overview
Table 73. Meridian Bioscience, Inc. Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Nucleic Acid Amplification Detection and Diagnostics Business of Meridian Bioscience, Inc. (2019-2024)
Table 75. Meridian Bioscience, Inc. Recent Developments
Table 76. F. Hoffmann-La Roche Ltd. Basic Information List
Table 77. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 78. F. Hoffmann-La Roche Ltd. Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Nucleic Acid Amplification Detection and Diagnostics Business of F. Hoffmann-La Roche Ltd. (2019-2024)
Table 80. F. Hoffmann-La Roche Ltd. Recent Developments
Table 81. PreAnalytiX Basic Information List
Table 82. PreAnalytiX Description and Business Overview
Table 83. PreAnalytiX Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Nucleic Acid Amplification Detection and Diagnostics Business of PreAnalytiX (2019-2024)
Table 85. PreAnalytiX Recent Developments
Table 86. Eiken Chemical Basic Information List
Table 87. Eiken Chemical Description and Business Overview
Table 88. Eiken Chemical Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
Table 89. Revenue (US$ Million) in Nucleic Acid Amplification Detection and Diagnostics Business of Eiken Chemical (2019-2024)
Table 90. Eiken Chemical Recent Developments
Table 91. Lucigen Basic Information List
Table 92. Lucigen Description and Business Overview
Table 93. Lucigen Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
Table 94. Revenue (US$ Million) in Nucleic Acid Amplification Detection and Diagnostics Business of Lucigen (2019-2024)
Table 95. Lucigen Recent Developments
Table 96. OptiGene Basic Information List
Table 97. OptiGene Description and Business Overview
Table 98. OptiGene Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
Table 99. Revenue (US$ Million) in Nucleic Acid Amplification Detection and Diagnostics Business of OptiGene (2019-2024)
Table 100. OptiGene Recent Developments
Table 101. NEB Basic Information List
Table 102. NEB Description and Business Overview
Table 103. NEB Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
Table 104. Revenue (US$ Million) in Nucleic Acid Amplification Detection and Diagnostics Business of NEB (2019-2024)
Table 105. NEB Recent Developments
Table 106. Quidel Corporation Basic Information List
Table 107. Quidel Corporation Description and Business Overview
Table 108. Quidel Corporation Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
Table 109. Revenue (US$ Million) in Nucleic Acid Amplification Detection and Diagnostics Business of Quidel Corporation (2019-2024)
Table 110. Quidel Corporation Recent Developments
Table 111. Promega Basic Information List
Table 112. Promega Description and Business Overview
Table 113. Promega Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
Table 114. Revenue (US$ Million) in Nucleic Acid Amplification Detection and Diagnostics Business of Promega (2019-2024)
Table 115. Promega Recent Developments
Table 116. Hologic Basic Information List
Table 117. Hologic Description and Business Overview
Table 118. Hologic Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
Table 119. Revenue (US$ Million) in Nucleic Acid Amplification Detection and Diagnostics Business of Hologic (2019-2024)
Table 120. Hologic Recent Developments
Table 121. Ustar Basic Information List
Table 122. Ustar Description and Business Overview
Table 123. Ustar Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
Table 124. Revenue (US$ Million) in Nucleic Acid Amplification Detection and Diagnostics Business of Ustar (2019-2024)
Table 125. Ustar Recent Developments
Table 126. Grifols Basic Information List
Table 127. Grifols Description and Business Overview
Table 128. Grifols Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
Table 129. Revenue (US$ Million) in Nucleic Acid Amplification Detection and Diagnostics Business of Grifols (2019-2024)
Table 130. Grifols Recent Developments
Table 131. Nugen Basic Information List
Table 132. Nugen Description and Business Overview
Table 133. Nugen Nucleic Acid Amplification Detection and Diagnostics Products, Services and Solutions
Table 134. Revenue (US$ Million) in Nucleic Acid Amplification Detection and Diagnostics Business of Nugen (2019-2024)
Table 135. Nugen Recent Developments
Table 136. Key Raw Materials Lists
Table 137. Raw Materials Key Suppliers Lists
Table 138. Nucleic Acid Amplification Detection and Diagnostics Downstream Customers
Table 139. Nucleic Acid Amplification Detection and Diagnostics Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
Table 143. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Nucleic Acid Amplification Detection and Diagnostics Product Picture
Figure 2. Global Nucleic Acid Amplification Detection and Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Nucleic Acid Amplification Detection and Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 4. Nucleic Acid Amplification Detection and Diagnostics Report Years Considered
Figure 5. Global Nucleic Acid Amplification Detection and Diagnostics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Nucleic Acid Amplification Detection and Diagnostics Revenue in 2023
Figure 7. Nucleic Acid Amplification Detection and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Polymerase Chain Reaction (PCR) Picture
Figure 9. Next Generation Sequencing (NGS) Picture
Figure 10. Isothermal Amplification Technology Picture
Figure 11. Direct Nucleic Acid Detection Picture
Figure 12. CRISPR-Cas9 Picture
Figure 13. Global Nucleic Acid Amplification Detection and Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Nucleic Acid Amplification Detection and Diagnostics Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Hospital and Clinics
Figure 16. Product Picture of Diagnostic Centers
Figure 17. Product Picture of Research Institutes
Figure 18. Product Picture of Others
Figure 19. Global Nucleic Acid Amplification Detection and Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Nucleic Acid Amplification Detection and Diagnostics Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Nucleic Acid Amplification Detection and Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Nucleic Acid Amplification Detection and Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Nucleic Acid Amplification Detection and Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Nucleic Acid Amplification Detection and Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Nucleic Acid Amplification Detection and Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Nucleic Acid Amplification Detection and Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Nucleic Acid Amplification Detection and Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Nucleic Acid Amplification Detection and Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Nucleic Acid Amplification Detection and Diagnostics Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Nucleic Acid Amplification Detection and Diagnostics Sales Value (%), (2019-2030)
Figure 32. United States Nucleic Acid Amplification Detection and Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Nucleic Acid Amplification Detection and Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Nucleic Acid Amplification Detection and Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Nucleic Acid Amplification Detection and Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Nucleic Acid Amplification Detection and Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Nucleic Acid Amplification Detection and Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 38. China Nucleic Acid Amplification Detection and Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Nucleic Acid Amplification Detection and Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 40. China Nucleic Acid Amplification Detection and Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Nucleic Acid Amplification Detection and Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Nucleic Acid Amplification Detection and Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Nucleic Acid Amplification Detection and Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Nucleic Acid Amplification Detection and Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Nucleic Acid Amplification Detection and Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Nucleic Acid Amplification Detection and Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Nucleic Acid Amplification Detection and Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Nucleic Acid Amplification Detection and Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Nucleic Acid Amplification Detection and Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 50. India Nucleic Acid Amplification Detection and Diagnostics Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Nucleic Acid Amplification Detection and Diagnostics Sales Value by Type (%), 2023 VS 2030
Figure 52. India Nucleic Acid Amplification Detection and Diagnostics Sales Value by Application (%), 2023 VS 2030
Figure 53. Nucleic Acid Amplification Detection and Diagnostics Industrial Chain
Figure 54. Nucleic Acid Amplification Detection and Diagnostics Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed